Literature DB >> 20876797

Silencing of thrombospondin-1 is critical for myc-induced metastatic phenotypes in medulloblastoma.

Limei Zhou1, Daniel Picard, Young-Shin Ra, Meihua Li, Paul A Northcott, Yaqi Hu, Duncan Stearns, Cynthia Hawkins, Michael D Taylor, James Rutka, Sandy D Der, Annie Huang.   

Abstract

Mechanisms by which c-Myc (Myc) amplification confers aggressive medulloblastoma phenotypes are poorly defined. Here, we show using orthotopic models that high Myc expression promotes cell migration/invasion and induces metastatic tumors, which recapitulate aggressive histologic features of Myc-amplified primary human medulloblastoma. Using ChIP-chip analysis, we identified cell migration and adhesion genes, including Tsp-1/THBS1, ING4, PVRL3, and PPAP2B, as Myc-bound loci in medulloblastoma cells. Expression of Tsp-1 was most consistently and robustly diminished in medulloblastoma cell lines and primary human tumors with high Myc expression (n = 101, P = 0.032). Strikingly, stable Tsp-1 expression significantly attenuated in vitro transformation and invasive/migratory properties of high Myc-expressing medulloblastoma cells without altering cell proliferation, whereas RNA interference-mediated Myc knockdown was consistently accompanied by increased Tsp-1 levels and reduced cell migration and invasion in medulloblastoma cells. Chromatin immunoprecipitation (ChIP) assays revealed colocalization of Myc and obligate partner Max and correlated diminished RNA polymerase II occupancy (∼3-fold decrease, P < 0.01) with increased Myc binding at a core Tsp-1 promoter. Reporter gene and/or gel shift assays confirmed direct repression of Tsp-1 transcription by Myc and also identified JPO2, a Myc interactor associated with metastatic medulloblastoma, as a cofactor in Myc-mediated Tsp-1 repression. These findings indicate the Myc-regulatory network targets Tsp-1 via multiple mechanisms in medulloblastoma transformation, and highlight a novel critical role for Tsp-1 in Myc-mediated aggressive medulloblastoma phenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876797     DOI: 10.1158/0008-5472.CAN-09-4562

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.

Authors:  J Chapman; A J Gentles; V Sujoy; F Vega; C I Dumur; T L Blevins; L Bernal-Mizrachi; M Mosunjac; A Pimentel; D Zhu; I S Lossos
Journal:  Leukemia       Date:  2015-04-24       Impact factor: 11.528

2.  Genome-Wide Analysis of c-MYC-Regulated mRNAs and miRNAs and c-MYC DNA-Binding by Next-Generation Sequencing.

Authors:  Rene Jackstadt; Markus Kaller; Antje Menssen; Heiko Hermeking
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Medulloblastoma: recurrence and metastasis.

Authors:  Donya Aref; Sidney Croul
Journal:  CNS Oncol       Date:  2013-07

4.  Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.

Authors:  Penny L Berger; Sander B Frank; Veronique V Schulz; Eric A Nollet; Mathew J Edick; Brittany Holly; Ting-Tung A Chang; Galen Hostetter; Suwon Kim; Cindy K Miranti
Journal:  Cancer Res       Date:  2014-04-24       Impact factor: 12.701

5.  Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.

Authors:  Irina Nesterenko; Simone Wanningen; Tugba Bagci-Onder; Maarten Anderegg; Khalid Shah
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 6.  Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Int J Mol Sci       Date:  2013-06-07       Impact factor: 5.923

Review 7.  The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.

Authors:  Renumathy Dhanasekaran; Anja Deutzmann; Wadie D Mahauad-Fernandez; Aida S Hansen; Arvin M Gouw; Dean W Felsher
Journal:  Nat Rev Clin Oncol       Date:  2021-09-10       Impact factor: 66.675

8.  RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification.

Authors:  Paulina Ćwiek; Zaira Leni; Fabiana Salm; Valeriya Dimitrova; Beata Styp-Rekowska; Gianpaolo Chiriano; Michael Carroll; Katrin Höland; Valentin Djonov; Leonardo Scapozza; Patrick Guiry; Alexandre Arcaro
Journal:  Oncotarget       Date:  2015-01-01

9.  Thrombospondin-1 signaling through CD47 inhibits self-renewal by regulating c-Myc and other stem cell transcription factors.

Authors:  Sukhbir Kaur; David R Soto-Pantoja; Erica V Stein; Chengyu Liu; Abdel G Elkahloun; Michael L Pendrak; Alina Nicolae; Satya P Singh; Zuqin Nie; David Levens; Jeffrey S Isenberg; David D Roberts
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  ID3 contributes to cerebrospinal fluid seeding and poor prognosis in medulloblastoma.

Authors:  Ji Hoon Phi; Seung Ah Choi; Sang-Hee Lim; Joongyub Lee; Kyu-Chang Wang; Sung-Hye Park; Seung-Ki Kim
Journal:  BMC Cancer       Date:  2013-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.